ClinicalTrials.gg
CompletedNCT02026492Updated Mar 17, 2015

Exercise Challenge in a Cold Chamber

An interventional study of Exercise challenge in a cold chamber and Methacholine challenge in Exercise-induced Asthma, sponsored by Johann Wolfgang Goethe University Hospital. Completed at 1 site in Germany. Open to participants aged 6 Years to 45 Years. Per ClinicalTrials.gov, last updated 2015-03-17.

Sponsored by Johann Wolfgang Goethe University Hospital · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
79
Allocation
Non-randomized
Ages
6 Years to 45 Years
Sex
All
01

Study summary

The purpose of this study is to compare the exercise-challenge in a cold chamber at 2-4°C to the gold standard the metacholine challenge in subjects showing symptoms of exercise-induced bronchoconstriction. The sensitivity and repeatability of the exercise test will be measured.

Read the detailed description

Subjects suffering form exercise-induced bronchoconstriction (EIB) usually have a normal lung function testing at rest. To provoke asthma symptoms a provocation test is necessary, e.g., by bronchial methacholine testing or by a standardised exercise test on a treadmill. The correlation between methacholine and exercise test is fair, possibly because both methods measure different kinds of bronchial hyperresponsiveness. Moreover, the sensitivity and the repeatability of the exercise test is fair.

The value of the methacholine test to predict a positive exercise test will be measured. We hypothesize that the exercise test in a cold chamber, a combination of two provocation methods cold air and exercise, is more sensitive to detect EIB and that the test has a better repeatability.

02

Conditions studied

  • Exercise-induced Asthma

Keywords

  • exercise-induced bronchoconstriction
  • exercise-induced asthma
  • cold chamber
  • exercise challenge
  • cold air challenge
  • combined exercise- and cold-air challenge
  • methacholine challenge
03

In context

Asthma, Exercise-Induced

52 studies on the registry are indexed under Asthma, Exercise-Induced; 3 are open to participants now.

This study's enrollment of 79 is above the median of 47 across 40 interventional studies indexed under Asthma, Exercise-Induced.

Browse Asthma, Exercise-Induced studies →

Lead sponsor

Johann Wolfgang Goethe University Hospital is the lead sponsor of 160 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients: Age >6 and \<18 years
  • Subjects: Age >/=18 and \<45 years
  • sportive, 1-2x exercise per week
  • bronchial hyperresponsiveness in the medical history

Exclusion criteria

Exclusion Criteria:

  • lung function Forced vital capacity (FVC) \<80% and (FEV1) \<75%
  • chronic diseases or infections (e.g. , Tbc)
  • pregnancy
  • systemic -treatment
  • inhalative corticosteroid therapy or leukotriene antagonists \<14d
  • alcohol, substance or drug abuse
  • smokers
  • inability to capture extend and consequences of the study
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
79 participants (actual)

Study arms

  • Other
    40 patients aged 6-18 years

    All 40 patients with a diagnosis of asthma are recruited from the outpatients clinic of the department of Pediatric Pneumology and Allergology of the University Hospital Frankfurt. Patients undergo a methacholine challenge and two exercise challenges in a cold chamber and one exercise challenge in room temperature.

    Other: Exercise challenge in a cold chamber · Other: Methacholine challenge · Other: Exercise challenge in room temperature

  • Other
    40 subjects aged 18-45 years

    All subjects show bronchial hyperresponsiveness e.g. dyspnea when exercising in cold environment, in their medical history. Subjects undergo a methacholine challenge and exercise challenge in a cold chamber and one exercise challenge in room temperature.

    Other: Exercise challenge in a cold chamber · Other: Methacholine challenge · Other: Exercise challenge in room temperature

Interventions

  • OtherExercise challenge in a cold chamber

    Exercise challenge is defined as running on a treadmill for 6-8 minutes on submaximal work load in a cold chamber.

  • OtherMethacholine challenge

    nebulized metacholine administered at following doses: 0,01mg, 0,1mg, 0,4mg, 0,8mg und 1,6mg

  • OtherExercise challenge in room temperature

    Exercise challenge is defined as running on a treadmill for 6-8 minutes on submaximal work load in room temperature.

06

What researchers measure

Primary outcomes

  1. Agreement of metacholine challenge and the combined exercise/cold-air challenge

    Lung function will be measured prior and after methacholine- and exercise/cold-air challenges. The maximal fall in forced expiratory volume in one second (FEV1, percent predicted) after methacholine and cold air challenge will be compared by statistical correlation. For both methods the sensitivity and the specificity to predict an exercise induced asthma will be calculated by a receiver operating characteristic (ROC analysis). All subjects receive Salbutamol to relief them from bronchial constriction at the end of the test.

    Time frame: 3 months

Secondary outcomes

  1. Repeatability of the combined exercise/cold-air challenge

    The combined exercise/cold-air challenge will be performed twice within one week. Post challenge the FEV1 will be measured after 5, 10, 20, and 30 minutes. The maximal fall in FEV1 (percent predicted) and the area under the curve (AUC) will be compared. The agreement and the repeatability of the maximal fall in FEV1 and of the AUC will be measured by correlation and by the method of Bland and Altman.

    Time frame: 3 months

Other outcomes

  1. Agreement of the combined exercise/cold-air challenge with the Asthma-score

    All children who participate will fill the asthma control test (ACT) and all adult subjects will fill the asthma control questionnaire (ACQ). The asthma-score will be compared with the severity of the exercise induced asthma measured by the maximal fall in FEV1.

    Time frame: 3 months

07

Study locations

1 site
  • Goethe University Hospital Frankfurt
    Frankfurt, Hessen 60590, Germany
08

References and documents

Publications

  • Schulze J, Rosewich M, Riemer C, Dressler M, Rose MA, Zielen S. Methacholine challenge--comparison of an ATS protocol to a new rapid single concentration technique. Respir Med. 2009 Dec;103(12):1898-903. doi: 10.1016/j.rmed.2009.06.007. Epub 2009 Jul 10. PubMed 19596563 ↗
  • Anderson SD. Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010 Aug;138(2 Suppl):25S-30S. doi: 10.1378/chest.10-0116. PubMed 20668015 ↗
  • Parsons JP, Hallstrand TS, Mastronarde JG, Kaminsky DA, Rundell KW, Hull JH, Storms WW, Weiler JM, Cheek FM, Wilson KC, Anderson SD; American Thoracic Society Subcommittee on Exercise-induced Bronchoconstriction. An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 2013 May 1;187(9):1016-27. doi: 10.1164/rccm.201303-0437ST. PubMed 23634861 ↗
  • Anderson SD, Charlton B, Weiler JM, Nichols S, Spector SL, Pearlman DS; A305 Study Group. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res. 2009 Jan 23;10(1):4. doi: 10.1186/1465-9921-10-4. PubMed 19161635 ↗
  • Driessen JM, van der Palen J, van Aalderen WM, de Jongh FH, Thio BJ. Inspiratory airflow limitation after exercise challenge in cold air in asthmatic children. Respir Med. 2012 Oct;106(10):1362-8. doi: 10.1016/j.rmed.2012.06.017. Epub 2012 Jul 11. PubMed 22789953 ↗
  • Dressler M, Friedrich T, Lasowski N, Herrmann E, Zielen S, Schulze J. Predictors and reproducibility of exercise-induced bronchoconstriction in cold air. BMC Pulm Med. 2019 May 16;19(1):94. doi: 10.1186/s12890-019-0845-3. PubMed 31097027 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 17, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02026492
Responsible party
Johannes Schulze MD (Consultant Pediatric Allergy and Pneumology, Johann Wolfgang Goethe University Hospital) — Principal investigator
First posted
Jan 3, 2014
Start date
Jun 2013
Primary completion
Jul 2014
Completion
Jul 2014
Last update
Mar 17, 2015

Study contacts

Johannes Schulze, MD
study chair · Johann Wolfgang Goethe University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion